|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Customer-perceived value in industrial contexts显示文摘 | Jozée Lapierre | 2000 | Journal of Business & Industrial Marketing2000,,2: | 1 |
| 2 | Scaling resistance of high performance concretes containing a small portion of pre-wetted lightweight fine aggregate显示文摘 | JOZ D WIEDZKA N | 2005 | Cement and Concrete Composites2005,27,6: | 1 |
| 3 | Electronic spin transport and spin precession insingle graphene layers at room temperature 显示文摘 | Tombros N Joz s a C Pop i nc i uc M e t al | | Nature0,448,: | 1 |
| 4 | Grafting tomato(Solanum lycopersicum) onto the rootstock of a high-alti- tude accession of Solanum habrochaites improves subopti- mal-temperature tolerance 显示文摘 | Jan H V Boukelien E D Joz'e M B | 2008 | Environ Exp Bot2008,63,: | 1 |
| 5 | Assessment of a pay-for-performance program in primary care designed by target users显示文摘 | Kirsten K Jozé B Reinier P A | 2013 | Family Practice2013,,30: | 1 |
| 6 | Teleporting an Unknown Quantum State via Dual Classical and Einstein- Podolsky-Rosen Channels 显示文摘 | BENNETT C H BRASSARD G JOZS R | 1993 | Phys Rev Lett1993,70,13: | 1 |
| 7 | Neurological Disorders in Primary Sj?gren’s Syndrome显示文摘 | Gabriel J. Tobón Jacques-Olivier Pers Valérie Devauchelle-Pensec Pierre Youinou Jozélio Freire de Carvalho | 2012 | Autoimmune Diseases2012,,: | 1 |
| 8 | A Kantorovich variant of a new type Bern- stein-Stancu polynomials 显示文摘 | JOZ G | 2012 | Appl Math Comput2012,218,1: | 1 |
| 9 | Catalytic properties of Pd supported on ZnO/ZnAl2O4/Al2O3 mixtures in dimethyl ether autotherrnal reforming显示文摘 | Nilsson M Jansson K Jozs P | 2009 | Applied Catalysis B:Environmental2009,86,12: | 1 |
| 10 | Symbolic two-dimensional minimization of strongly unspecified finite state machines显示文摘 | M A Perkowski L Joz wiak W Zhao | 2001 | Journal of Systems Architecture2001,47,: | 1 |
| 11 | Statistical Modeling for the Mitigation of GPS Multipath Delays from Day-to- day Range Measurements显示文摘 | Joz W Hsieh C H | 2010 | J Geod2010,,84: | 1 |
| 12 | Municipal landfill leachate nitrification in RBC biofilm - process efficiency and molecular analysis of microbial structure 显示文摘 | Dorota Kulikowska Tomasz Joz'wiak Przernyslaw Kowal | 2010 | Biore- source Technology2010,101,: | 1 |
| 13 | Conductometric investigation of dye-surfactant ion pair formation in aqueous solution显示文摘 | SABINA Bracko JOZ E Span | 2000 | Dyes and Pigments2000,,45: | 1 |
| 14 | Lidocaine in fibromyalgia:A systematic review显示文摘BACKGROUND Fibromyalgia(FM)patients are treated with antidepressants,and in most cases,these drugs lose efficacy or present side effects.Intravenous lidocaine(IL)is an anesthetic drug used in some FM trials.AIM To systematically review the safety and efficacy of IL in FM patients.METHODS To systematically search PubMed for articles in English,Spanish,and Japanese with English Abstracts on FM and lidocaine between 1966 and February 2021.This study was registered at PROSPERO.RESULTS We found only ten articles published in this field,with a total of 461 patients.Females predominated varying from 95%to 100%in the studies.Age varied from 40.9 to 55 years old.Disease duration varied from 1 mo to 6.4 years.Lidocaine dose varied from 2 to 7.5 mg/kg via intravenous infusion.Follow-up period varied from 65.7 to 90 days.Regarding outcomes,most studies used the visual analogue scale(VAS)for pain;before short-term lidocaine administration,VAS was between 6.1 and 8.1 and after treatment was between 1.7 and 4.5 mm.Concerning long term lidocaine,VAS varied from 30%to 35.4%after lidocaine infusion.Side effects were observed in 0%to 39.6%of cases,they were usually mild or moderate.CONCLUSION This study demonstrates the short-term effectiveness and safety of intravenous lidocaine in FM patients.However,more studies,including long-term follow-up,are still needed. | Jozélio Freire de Carvalho Thelma L Skare | 2022 | World Journal of Psychiatry2022,12,4: | 0 |
| 15 | Suicide risk in systemic lupus erythematosus:A narrative review显示文摘Introduction:Despite the medical and scientific advances,the disease’s restrictions and the perception of personal and social losses related to its course reinforce fear and generate intense suffering in lupus patients.Psychiatric comorbidities,especially major depressive episodes,are highly prevalent during systemic lupus erythematosus.Among them,suicide is a behavior that is much more common than we believe.Objective:To perform a narrative review on suicidal behavior associated with systemic erythematosus lupus(SLE).Results:Studies have shown an increased risk of suicide among patients with chronic diseases and psychiatric disorders,especially depression.However,suicide cannot be attributed only to a higher prevalence of depression and other mental illnesses.Therefore,it is necessary to learn more about the suicide risk factors present in patients with lupus to work on secondary prevention and avoid the premature loss of lives and the additional suffering of families and surrounding communities.The coordination between the studies on suicidal behavior and its intricate network of individual and sociocultural factors and the studies on this multisystem autoimmune disease with a broad manifestation spectrum,lupus,creates new and essential field research.Conclusions:Non-psychiatrist office-based physicians,health clinics,or wards dedicated to the treatment of SLE should recognize and handle the suicide risk factors on their patients to reduce the suffering caused by this disease. | Solange Barros Jozélio Freire de Carvalho | 2021 | Discussion of Clinical Cases2021,8,3: | 0 |
| 16 | Evaluation of materno-fetal antibody transfer in patients with antiphospholipid syndrome显示文摘Introduction:Antiphospholipid syndrome(APS)is characterized by thrombotic events and recurrent pregnancy losses and is considered the most common acquired thrombophilia.Objective:To carry out a narrative review of the transplacental passage and antibodies in patients with APS.Methods:A narrative literature review Results:When it is not associated with any connective tissue disease,it is said to be primary,and when in association with systemic lupus erythematosus,it is said to be secondary.Gestational morbidity is frequent,and it is crucial to evaluate the passage of these antibodies transplacentally since there are animal models of the syndrome with passive transfer of these antibodies.The transplacental passage of specific antibodies has already been determined in studies,which demonstrated low levels of these antibodies in the maternal serum,but an efficient transplacental passage for the newborn.Conclusions:There are few studies on this maternal-infant passage in patients with APS reviewed here. | Magda Carneiro-Sampaio Jozélio Freire de Carvalho | 2021 | Discussion of Clinical Cases2021,8,3: | 0 |
| 17 | Presarcopenia and chronic cough due to chronic obstructive pulmonary disease successfully treated with nutraceutical supplements and physical exercise显示文摘Objective:To describe a patient with presarcopenia and chronic cough secondary to chronic obstructive pulmonary disease(COPD)successfully treated with supplements and physical exercise.Case report:A 75-year-old female patient with a positive past medical history of systemic hypertension,dyslipidemia,heart arrhythmia,and smoking during 20 years evolved with chronic cough due to a chronic obstructive pulmonary disease diagnosed ten years ago.She came to our private clinic due to low weight,low energy.Her weight was 44.8 kg,her height 1.57 m,body mass index of 18.18 kg/m^(2).Laboratory tests showed SDHEA 76.3,vitamin D of 15.6 ng/ml(nr:>30 ng/ml),C-reactive protein(CRP)of 55 mg/ml.Computed tomography showed bronchiectasis.She had an skeletal muscle mass index of 5.0 kg/m^(2)(nr:>5.5 kg/m^(2))by DXA.A diagnosis of presarcopenia was determined based on DXA evaluation with low muscle mass but normal gait speed handgrip strength.We suggested to the patient to increase physical exercise and prescribed a supplement formula.After five months,she returned asymptomatic,without cough,marked improvement of fatigue,increased energy levels,and weight increased to 50 kg,BMI of 20.28 kg/m^(2).Laboratory tests showed SDHEA to 140,vitamin D3 to 64.5 ng/ml,reduced CRP reduced to 5 mg/dl,and amlodipine was excluded due to better blood pressure control.Currently,two years later,the patient continues without cough and has dyspnea only with high efforts,without fatigue,and her weight is 52 kg and BMI 21.1 kg/m^(2).She also reduced her conventional treatment for COPD,using only a bronchodilator on-demand,without topical corticoids.Conclusions:This case illustrates an interesting case of a patient with presarcopenia and chronic cough,refractory to conventional approach,successfully treated with a combination of nutraceuticals and physical exercises. | Jozélio Freire de Carvalho Aaron Lerner | 2021 | Discussion of Clinical Cases2021,8,4: | 0 |
| 18 | Metabolic and nutritional triggers associated with increased risk of liver complications in SARS-CoV-2显示文摘Obesity,diabetes,cardiovascular and respiratory diseases,cancer and smoking are risk factors for negative outcomes in severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),which can quickly induce severe respiratory failure in 5%of cases.Coronavirus disease-associated liver injury may occur during progression of SARS-CoV-2 in patients with or without pre-existing liver disease,and damage to the liver parenchyma can be caused by infection of hepatocytes.Cirrhosis patients may be particularly vulnerable to SARS-CoV-2 if suffering with cirrhosis-associated immune dysfunction.Furthermore,pharmacotherapies including macrolide or quinolone antibiotics and steroids can also induce liver damage.In this review we addressed nutritional status and nutritional interventions in severe SARS-CoV-2 liver patients.As guidelines for SARS-CoV-2 in intensive care(IC)specifically are not yet available,strategies for management of sepsis and SARS are suggested in SARS-CoV-2.Early enteral nutrition(EN)should be started soon after IC admission,preferably employing iso-osmolar polymeric formula with initial protein content at 0.8 g/kg per day progressively increasing up to 1.3 g/kg per day and enriched with fish oil at 0.1 g/kg per day to 0.2 g/kg per day.Monitoring is necessary to identify signs of intolerance,hemodynamic instability and metabolic disorders,and transition to parenteral nutrition should not be delayed when energy and protein targets cannot be met via EN.Nutrients including vitamins A,C,D,E,B6,B12,folic acid,zinc,selenium andω-3 fatty acids have in isolation or in combination shown beneficial effects upon immune function and inflammation modulation.Cautious and monitored supplementation up to upper limits may be beneficial in management strategies for SARS-CoV-2 liver patients. | Rosangela Passos de Jesus Jozélio Freire de Carvalho Lucivalda Pereira Magalhães de Oliveira Carla de Magalhães Cunha Thaisy Cristina Honorato Santos Alves Sandra Tavares Brito Vieira Virginia Maria Figueiredo Allain Amador Bueno | 2022 | World Journal of Hepatology2022,14,1: | 0 |